tiprankstipranks
Trending News
More News >
Dr. Reddy's Laboratories Ltd. (IN:DRREDDY)
:DRREDDY
India Market

Dr. Reddy's Laboratories Ltd. (DRREDDY) Stock Statistics & Valuation Metrics

Compare
2 Followers

Total Valuation

Dr. Reddy's Laboratories Ltd. has a market cap or net worth of ₹1.04T. The enterprise value is ―.
Market Cap₹1.04T
Enterprise Value

Share Statistics

Dr. Reddy's Laboratories Ltd. has 834,416,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding834,416,300
Owned by Insiders
Owned by Institutions

Financial Efficiency

Dr. Reddy's Laboratories Ltd.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)
Return on Assets (ROA)
Return on Invested Capital (ROIC)
Return on Capital Employed (ROCE)
Revenue Per Employee
Profits Per Employee
Employee Count
Asset Turnover
Inventory Turnover

Valuation Ratios

The current PE Ratio of Dr. Reddy's Laboratories Ltd. is ―. Dr. Reddy's Laboratories Ltd.’s PEG ratio is ―.
PE Ratio
PS Ratio0.00
PB Ratio
Price to Fair Value
Price to FCF
Price to Operating Cash Flow
PEG Ratio

Income Statement

In the last 12 months, Dr. Reddy's Laboratories Ltd. had revenue of 279.16B and earned 55.68B in profits. Earnings per share was 334.41.
Revenue279.16B
Gross Profit163.61B
Operating Income67.73B
Pretax Income71.87B
Net Income55.68B
EBITDA88.28B
Earnings Per Share (EPS)334.41

Cash Flow

In the last 12 months, operating cash flow was 35.42B and capital expenditures -29.43B, giving a free cash flow of 5.99B billion.
Operating Cash Flow35.42B
Free Cash Flow5.99B
Free Cash Flow per Share7.18

Dividends & Yields

Dr. Reddy's Laboratories Ltd. pays an annual dividend of ₹8, resulting in a dividend yield of 0.64%
Dividend Per Share₹8
Dividend Yield0.64%
Payout Ratio11.80%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.73
52-Week Price Change10.02%
50-Day Moving Average1.19K
200-Day Moving Average1.26K
Relative Strength Index (RSI)76.32
Average Volume (3m)68.10K

Important Dates

Dr. Reddy's Laboratories Ltd. upcoming earnings date is Jul 24, 2025, TBA Not Confirmed.
Last Earnings DateMay 9, 2025
Next Earnings DateJul 24, 2025
Ex-Dividend DateJul 10, 2025

Financial Position

Dr. Reddy's Laboratories Ltd. as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio
Quick Ratio
Debt to Market Cap
Net Debt to EBITDA
Interest Coverage Ratio

Taxes

In the past 12 months, Dr. Reddy's Laboratories Ltd. has paid 16.19B in taxes.
Income Tax16.19B
Effective Tax Rate

Enterprise Valuation

Dr. Reddy's Laboratories Ltd. EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales
EV to EBITDA
EV to Free Cash Flow
EV to Operating Cash Flow

Balance Sheet

Dr. Reddy's Laboratories Ltd. has ₹59.18B in cash and marketable securities with ₹51.09B in debt, giving a net cash position of -₹8.09B billion.
Cash & Marketable Securities₹59.18B
Total Debt₹51.09B
Net Cash-₹8.09B
Net Cash Per Share-₹9.70
Tangible Book Value Per Share

Margins

Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin
Operating Margin
Pretax Margin
Net Profit Margin
EBITDA Margin
EBIT Margin

Analyst Forecast

The average price target for Dr. Reddy's Laboratories Ltd. is ₹1,291.67, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹1,291.67
Price Target Upside12.45% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis